Medical expenditure for esophageal cancer in China: a 10-year multicenter retrospective survey (2002-2011)

HFCAS OpenIR

	Medical expenditure for esophageal cancer in China: a 10-year multicenter retrospective survey (2002-2011)
其他题名	Medical expenditure for esophageal cancer in China: a 10-year multicenter retrospective survey (2002–2011)
	2017
发表期刊	CHINESE JOURNAL OF CANCER
ISSN	1000-467X
摘要	Background: Esophageal cancer is associated with substantial disease burden in China, and data on the economic burden are fundamental for setting priorities in cancer interventions. The medical expenditure for the diagnosis and treatment of esophageal cancer in China has not been fully quantified. This study aimed to examine the medical expenditure of Chinese patients with esophageal cancer and the associated trends.
其他摘要	Background Esophageal cancer is associated with substantial disease burden in China, and data on the economic burden are fundamental for setting priorities in cancer interventions. The medical expenditure for the diagnosis and treatment of esophageal cancer in China has not been fully quantified. This study aimed to examine the medical expenditure of Chinese patients with esophageal cancer and the associated trends. Methods From 2012 to 2014, a hospital-based multicenter retrospective survey was conducted in 37 hospitals in 13 provinces Results A total of 14,967 esophageal cancer patients were included in the analysis. It was estimated that the overall average expenditure per patient was 38,666 CNY, and an average annual increase of 6.27% was observed from 2002 (25,111 CNY) to 2011 (46,124 CNY). The average expenditures were 34,460 CNY for stage I, 39,302 CNY for stage II, 40,353 CNY for stage III, and 37,432 CNY for stage IV diseases ( P <0.01). The expenditure also differed by the therapy type, which was 38,492 CNY for surgery, 27,933 CNY for radiotherapy, and 27,805 CNY for chemotherapy ( P <0.05). Drugs contributed to 45.02% of the overall expenditure. Conclusions These conservative estimates suggested that medical expenditures for esophageal cancer in China substantially increased in the last 10years, treatment for early-stage esophageal cancer costs less than that for advanced cases, and spending on drugs continued to account for a considerable proportion of the overall expenditure.
关键词	HOSPITAL COSTS UNITED-STATES DIAGNOSIS CARE Esophageal neoplasms Medical expenditure Diagnosis and treatment China
收录类别	CSCD
语种	英语
资助项目	[National Health and Family Plan Commission of P.R. China]
CSCD记录号	CSCD:6179341
引用统计
文献类型	期刊论文
条目标识符	http://ir.hfcas.ac.cn:8080/handle/334002/51213
专题	中国科学院合肥物质科学研究院
推荐引用方式 GB/T 7714	. Medical expenditure for esophageal cancer in China: a 10-year multicenter retrospective survey (2002-2011)[J]. CHINESE JOURNAL OF CANCER,2017,36.
APA	(2017).Medical expenditure for esophageal cancer in China: a 10-year multicenter retrospective survey (2002-2011).CHINESE JOURNAL OF CANCER,36.
MLA	"Medical expenditure for esophageal cancer in China: a 10-year multicenter retrospective survey (2002-2011)".CHINESE JOURNAL OF CANCER 36(2017).